DrugPatentWatch Database Preview
Aripiprazole lauroxil - Generic Drug Details
What are the generic drug sources for aripiprazole lauroxil and what is the scope of aripiprazole lauroxil freedom to operate?
Aripiprazole lauroxil
is the generic ingredient in two branded drugs marketed by Alkermes Inc and is included in two NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.Aripiprazole lauroxil has ninety-five patent family members in twenty-six countries.
There are forty-nine drug master file entries for aripiprazole lauroxil. One supplier is listed for this compound.
Summary for aripiprazole lauroxil
| International Patents: | 95 |
| US Patents: | 8 |
| Tradenames: | 2 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Master File Entries: | 49 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 13 |
| Clinical Trials: | 5 |
| Patent Applications: | 35 |
| DailyMed Link: | aripiprazole lauroxil at DailyMed |
Synonyms for aripiprazole lauroxil
| (7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinolin-1(2H)-yl)methyl dodecanoate |
| [7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-2-oxo-3,4-dihydroquinolin-1-yl]methyl dodecanoate |
| [7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-2-oxo-3,4-dihydroquinolin-1(2H)-yl]methyl dodecanoate |
| 1259305-29-7 |
| AKOS030627657 |
| ALKS 9070 |
| ALKS 9072 |
| Aripiprazol- Lauroxil |
| Aripiprazole lauroxil (USAN) |
| Aripiprazole lauroxil [USAN] |
| Aristada |
| Aristada (TN) |
| AS-35241 |
| B786J7A343 |
| BCP14993 |
| CHEBI:90930 |
| CHEMBL2219425 |
| D10364 |
| Dodecanoic acid [7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2-oxo-1(2H)-quinolinyl]methyl ester |
| Dodecanoic acid, (7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2-oxo-1(2H)-quinolinyl)methyl ester |
| DTXSID60154997 |
| RDC 3317 |
| RDC-3317 |
| SCHEMBL1044330 |
| UNII-B786J7A343 |
| ZINC95564895 |
US Patents and Regulatory Information for aripiprazole lauroxil
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-002 | Oct 5, 2015 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-004 | Jun 5, 2017 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Alkermes Inc | ARISTADA INITIO KIT | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 209830-001 | Jun 29, 2018 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for aripiprazole lauroxil
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1210033 | ➤ Try a Free Trial |
| Denmark | 2685979 | ➤ Try a Free Trial |
| Japan | 2017524021 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for aripiprazole lauroxil
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1675573 | C300669 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOLE; REGISTRATION NO/DATE: EU/1/13/882 20131115 |
| 1675573 | 92427 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOLE |
| 1675573 | 300669 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOLE; REGISTRATION NO/DATE: EU/1/13/882 20131115 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
